share_log

Scotiabank Maintains Sector Outperform on Pacific Biosciences, Lowers Price Target to $8

Moomoo 24/7 ·  Apr 18 07:22

Scotiabank analyst Sung Ji Nam maintains Pacific Biosciences (NASDAQ:PACB) with a Sector Outperform and lowers the price target from $15 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment